Laurus Labs

Laurus Labs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Laurus Labs (LAURUSLABS.NS) as of Oct 11, 2026 is 12.98 B INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 11.34 B INR — a change of 14.40% (higher).

EBITDA

12.98 BINR

YoY

14.40%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Laurus Labs is 2026 12.98 B INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Laurus Labs was 2025 11.34 B INR. It decreases by 14.40% higher compared to the previous year.

The Laurus Labs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
8.75 B INR
Jan 1, 2020
5.70 B INR
Jan 1, 2021
23.64 B INR
Jan 1, 2022
24.04 B INR
Jan 1, 2023
28.80 B INR
Jan 1, 2024
7.98 B INR
Jan 1, 2025
11.34 B INR
Jan 1, 2026
12.98 B INR
The Laurus Labs EBITDA history
YEAREBITDAYoY
12.98 BINR+14.40%
11.34 BINR+42.16%
7.98 BINR-72.29%
28.80 BINR+19.77%
24.04 BINR+1.70%
23.64 BINR+314.45%
5.70 BINR-34.79%
8.75 BINR+5.71%
8.28 BINR+8.56%
7.62 BINR+18.22%
6.45 BINR+204.36%
2.12 BINR+15.60%
1.83 BINR—
Access this data via the Eulerpool API
Get Free API Key

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laurus Labs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Laurus Labs is 12.98 B INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Laurus Labs changed from 11.34 B INR to 12.98 B INR, representing a 14.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Laurus Labs historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Laurus Labs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Laurus Labs